Actionable news
0
All posts from Actionable news
Actionable news in EDAP: EDAP TMS S.A.,

EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016

  • Total EDAP revenue up 20.4% year-over-year in the first six months of 2016
  • Continued growth in HIFU system sales and treatment-driven revenue with strong margins
  • Focal One® 510k under FDA review
  • Solid cash position at €21.9 million as of June 30, 2016

LYON, France, Aug. 25, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, announced today financial results for the second quarter and six months ended June 30, 2016, and provided an update on strategic and operational accomplishments.

Marc Oczachowski, EDAP’s Chief Executive Officer, stated, “EDAP has made steady progress in the first half of the year. The FDA clearance of Ablatherm Robotic HIFU in late 2015 has resulted in strong system sales, while the growth in treatment driven revenues continued as a result of the traction and momentum of HIFU globally.”

“The solid performance of the HIFU division, in which revenues increased 69% over the first half of 2015, is clear evidence that our market penetration strategy is working and supports the expansion and growth of our global HIFU business. We continue penetrating the U.S. market with our strategy of targeting large and recognized institutions directly, while also providing access to the entire urology community by partnering with mobilizers and service providers.

In April, we submitted a 510(k) application for our next generation...


More